|
SGEF expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.21019999763806E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.51280000140852E-08 |
| Normal-vs-Stage2 |
7.55510000005621E-07 |
| Normal-vs-Stage3 |
1.80864999999031E-05 |
| Normal-vs-Stage4 |
2.617100E-03 |
| Stage1-vs-Stage2 |
2.419800E-01 |
| Stage1-vs-Stage3 |
8.065800E-02 |
| Stage1-vs-Stage4 |
3.589400E-01 |
| Stage2-vs-Stage3 |
5.126600E-01 |
| Stage2-vs-Stage4 |
6.550200E-01 |
| Stage3-vs-Stage4 |
9.530600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.68719999772105E-08 |
| Normal-vs-AfricanAmerican |
7.7766999950768E-08 |
| Normal-vs-Asian |
1.61057999999992E-05 |
| Caucasian-vs-AfricanAmerican |
8.783800E-01 |
| Caucasian-vs-Asian |
5.730600E-01 |
| AfricanAmerican-vs-Asian |
5.639200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.79260000071824E-08 |
| Normal-vs-Female |
1.05510000003584E-06 |
| Male-vs-Female |
1.630380E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.0552000002414E-07 |
| Normal-vs-Extreme_Weight |
3.61940000193073E-08 |
| Normal-vs-Obese |
5.28929999799033E-08 |
| Normal-vs-Extreme_Obese |
1.25360000047259E-07 |
| Normal_Weight-vs-Extreme_Weight |
3.080200E-01 |
| Normal_Weight-vs-Obese |
4.328600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.068800E-01 |
| Extreme_Weight-vs-Obese |
7.272200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.063800E-01 |
| Obese-vs-Extreme_Obese |
5.296200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.15229999997357E-06 |
| Normal-vs-Age(41-60Yrs) |
1.89710000042531E-07 |
| Normal-vs-Age(61-80Yrs) |
4.24339999804957E-08 |
| Normal-vs-Age(81-100Yrs) |
1.84520000390265E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.684400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.005000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.233430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.749790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.596100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.118000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.48909999570557E-08 |
| Normal-VS-Type2 PRCC |
1.1715999947981E-08 |
| Normal-VS-KIRP CIMP |
8.796500E-02 |
| Normal-VS-Unclassified PRCC |
4.89970000128181E-08 |
| Type1 PRCC-VS-Type2 PRCC |
8.105600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.23759999999196E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
6.105200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.359320E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
4.738200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.760900E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.92559999559572E-08 |
| Normal-vs-N1 |
1.236300E-03 |
| Normal-vs-N2 |
7.004800E-01 |
| N0-vs-N1 |
1.988260E-02 |
| N0-vs-N2 |
1.790450E-01 |
| N1-vs-N2 |
1.738010E-01 |
|
|
